Total Payments
$753.99
2019 Payments
$110.47
Companies
14
Transactions
42
Medicare Patients
798
Medicare Billing
$74,655
Payment Breakdown by Category
Food & Beverage$753.99 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $753.99 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $236.75 | 14 | $0 (2019) |
| Gilead Sciences Inc | $155.58 | 3 | $0 (2017) |
| Indivior Inc. | $66.28 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $54.26 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $39.58 | 3 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $38.44 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $28.86 | 2 | $0 (2017) |
| Lilly USA, LLC | $28.48 | 2 | $0 (2017) |
| PFIZER INC. | $24.93 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $21.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $110.47 | 7 | Janssen Pharmaceuticals, Inc ($39.47) |
| 2018 | $163.62 | 12 | Janssen Pharmaceuticals, Inc ($72.20) |
| 2017 | $479.90 | 23 | Gilead Sciences Inc ($155.58) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $14.96 | General |
| 08/06/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/24/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: PSYCHIATRY | ||||||
| 05/20/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: OUD | ||||||
| 04/17/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Hypertriglyceridemia | ||||||
| 01/22/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: OUD | ||||||
| 01/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/08/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: OUD | ||||||
| 08/20/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/13/2018 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Neuroscience | ||||||
| 07/31/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/11/2018 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Neuroscience | ||||||
| 05/08/2018 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: OUD | ||||||
| 05/02/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/24/2018 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Neuroscience | ||||||
| 03/05/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: OUD | ||||||
| 01/22/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/28/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug), BREO | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Neuroscience | ||||||
| 09/21/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: DIABETES | ||||||
| 08/29/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes | ||||||
| 07/27/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 305 | 391 | $118,104 | $27,844 |
| 2022 | 4 | 277 | 314 | $89,615 | $22,370 |
| 2021 | 5 | 216 | 257 | $69,664 | $24,441 |
Total Patients
798
Total Services
962
Medicare Billing
$74,655
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 77 | 102 | $43,473 | $10,318 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 100 | 134 | $40,670 | $8,688 | 21.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 62 | $11,128 | $3,766 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 57 | 63 | $12,920 | $2,928 | 22.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,900 | $1,399 | 28.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 16 | 16 | $5,013 | $746.37 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 93 | 124 | $36,104 | $9,382 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 65 | 70 | $28,300 | $7,800 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 55 | 56 | $11,010 | $2,800 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 35 | $9,835 | $1,658 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $3,420 | $427.26 | 12.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 11 | 11 | $946.00 | $303.38 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 143 | $39,591 | $13,891 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 40 | $15,323 | $5,541 | 36.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 51 | $9,540 | $3,362 | 35.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $4,610 | $1,449 | 31.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $600.00 | $196.80 | 32.8% |
About Dr. Brian Timms, D.O
Dr. Brian Timms, D.O is a Internal Medicine healthcare provider based in Sunbury, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811955875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Timms, D.O has received a total of $753.99 in payments from pharmaceutical and medical device companies, with $110.47 received in 2019. These payments were reported across 42 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($753.99).
As a Medicare-enrolled provider, Timms has provided services to 798 Medicare beneficiaries, totaling 962 services with total Medicare billing of $74,655. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Sunbury, PA
- Active Since 05/01/2006
- Last Updated 05/12/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811955875
Products in Payments
- XARELTO (Drug) $175.51
- Descovy (Drug) $113.29
- SUBLOCADE (Drug) $66.28
- JARDIANCE (Drug) $54.26
- INVEGA TRINZA (Drug) $42.75
- ENTRESTO (Drug) $39.58
- TRULICITY (Drug) $28.48
- SOLIQUA (Drug) $27.04
- ELIQUIS (Drug) $24.93
- INCRUSE (Drug) $21.85
- INVEGA SUSTENNA (Drug) $18.49
- Vascepa (Drug) $15.18
- FARXIGA (Drug) $15.16
- Kazano (Drug) $14.53
- ABILIFY MAINTENA (Drug) $14.31
- BEVESPI AEROSPHERE (Drug) $13.70
- TOUJEO (Drug) $11.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.